If you’ve seen talk about a white traffic light or images of a signal with an unfamiliar fourth color, you’re not imagining it. With everything drivers already pay attention to at intersections, ...

Screenshots and message logs obtained by The Crimson appear to show Salient leaders casually using racial slurs, defending extremist rhetoric, and dismissing internal concerns — conversations that ...

The Pentagon’s latest report makes one thing clear: Signal protects conversations, but it was never designed to safeguard U.S. war plans — and using it that way carried real risk for American forces.

A Pentagon inspector general report concluded that Secretary of War Pete Hegseth sent sensitive, nonpublic strike information over the encrypted app Signal using his personal phone, a violation of ...

A highly critical inspector general report found Defense Secretary Pete Hegseth jeopardized troop safety and violated department policy by using the Signal app on his personal cell phone to discuss a ...

The defense secretary has insisted no classified information was shared. A monthslong investigation into Defense Secretary Pete Hegseth's use of the commercial messaging app Signal is complete and its ...

A classified final version of the Pentagon inspector general’s report into Secretary of Defense Pete Hegseth’s use of Signal to discuss sensitive military operations has been delivered to the House ...

Forbes contributors publish independent expert analyses and insights. Davey Winder is a veteran cybersecurity writer, hacker and analyst. Updated November 25 with a new warning from America’s Cyber ...

Abstract: Throughput is a critical performance metric in backscatter communication systems. Existing approaches either suffer from limited throughput or necessitate modifications to transmitters or ...

The "Wow!" signal has been etched with a red marker in the memory of advocates for the search for extraterrestrial intelligence (SETI) since its unveiling in 1977. To this day, it remains one of the ...

Schrödinger's SGR-1505 Phase 1 data shows encouraging safety and niche efficacy, especially in BTKi-resistant Waldenström macroglobulinemia patients. Despite a headline 22% ORR, the nuanced data ...